SCHEMBL995479

SCHEMBL995479

CCCCCCCC(C)CCC(C)CCCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.67
OPRM1 P35372 1/20 0.52
LMNA P02545 2/20 0.50
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50
SPHK1 Q9NYA1 1/20 0.48
DNM1 Q05193 2/20 0.48
PRKD3 O94806 1/20 0.46
PRKCG P05129 1/20 0.46
PRKCB P05771 1/20 0.46
PRKCA P17252 1/20 0.46
PRKCH P24723 1/20 0.46
PRKCI P41743 1/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCZ Q05513 1/20 0.46
PRKCD Q05655 1/20 0.46
PRKD1 Q15139 1/20 0.46
ADH1B P00325 1/20 0.44
ADH1C P00326 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31187915 1.00 ACE2 (0.67) ACE2OPRM1LMNATSHRTHRB
SCHEMBL20506761 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL20835139 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL6760264 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL21086628 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL20506755 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL20506756 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL20506759 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL20506768 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB
SCHEMBL22129693 0.97 ACE2 (0.62) ACE2OPRM1LMNATSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230099694-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-03-30 US disclosed
US-20210052575-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-02-25 US disclosed
US-20200061056-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-02-27 US disclosed
US-20190167672-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-06-06 US disclosed
US-20180318294-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-11-08 US disclosed
US-20180092907-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-04-05 US disclosed
EP-2151233-B1 TWO-COMPONENT OXIDATIVE HAIR DYE COMPOSITION KAO CORP (JP) 2017-08-09 EP disclosed
EP-2151232-B1 OXIDATIVE HAIR DYE COMPOSITION KAO CORP (JP) 2017-04-12 EP disclosed
US-20170071933-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-03-16 US disclosed
EP-2753617-B9 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS OTSUKA PHARMA CO LTD (JP) 2017-01-25 EP disclosed
EP-1468665-A2 Hair cosmetic composition Kao Corporation (JP) 2004-10-20 EP disclosed
US-20040166084-A1 Hair cosmetic composition KAO CORPORATION (JP) 2004-08-26 US disclosed
US-20040156815-A1 Hair cleansing composition KAO CORPORATION (JP) 2004-08-12 US disclosed
US-20040157984-A1 Hair cleansing composition KAO CORPORATION (JP) 2004-08-12 US disclosed
EP-1433465-A2 Hair cosmetic composition Kao Corporation (JP) 2004-06-30 EP disclosed
EP-1433464-A2 Hair cleansing composition Kao Corporation (JP) 2004-06-30 EP disclosed
EP-1433466-A2 Hair cleansing composition Kao Corporation (JP) 2004-06-30 EP disclosed
US-20040115162-A1 Dermatological preparations KAO CORPORATION (JP) 2004-06-17 US disclosed
US-6685953-B1 WATER RETENTION CAPACITY; MOISTURIZER; ALKOXYALKYAMIDES OF ALKYLENEDICARBOXYLIC ACIDS KAO CORPORATION (JP) 2004-02-03 US disclosed
EP-1166766-A1 EXTERNAL PREPARATION COMPOSITIONS Kao Corporation (JP) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230099694-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, BRPF3, BRD4 ACE2 3755/4885OPRM1 1578/4885LMNA 4438/4885
US-20170071933-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, BRPF3, BRD4 ACE2 3755/4885OPRM1 1578/4885LMNA 4438/4885
US-20180318294-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, BRPF3, BRD4 ACE2 3755/4885OPRM1 1578/4885LMNA 4438/4885
US-20210052575-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, SULT2A1, CYP4Z1 ACE2 3451/4885OPRM1 1043/4885LMNA 4301/4885
US-20200061056-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, BRPF3, BRD4 ACE2 3755/4885OPRM1 1578/4885LMNA 4438/4885
US-20040166084-A1 Hair cosmetic composition H1-0, H1-2, SHH ACE2 4356/4885OPRM1 1566/4885LMNA 680/4885
US-20180092907-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, BRPF3, BRD4 ACE2 3755/4885OPRM1 1578/4885LMNA 4438/4885
US-20190167672-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS SUZ12, BRPF3, BRD4 ACE2 3755/4885OPRM1 1578/4885LMNA 4438/4885
US-20040156815-A1 Hair cleansing composition CUTA, TRPA1, SHH ACE2 4001/4885OPRM1 3604/4885LMNA 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.